BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4

• Press Releases

  Climb Bio to Present at Upcoming September 2026 Investor Conferences

  September 2, 2026

   · 

  1 min read
• Press Releases

  Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

  September 2, 2026

   · 

  9 min read
• Press Releases

  Axsome Therapeutics to Participate in Upcoming September 2026 Investor Conferences

  September 2, 2026

   · 

  5 min read
• Press Releases

  Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026

  September 2, 2026

   · 

  2 min read
• Press Releases

  Transpire Bio to Participate in Upcoming Healthcare Investor Conferences During September 2026

  September 2, 2026

   · 

  1 min read
• Press Releases

  Raziel Therapeutics and Fosun Pharma Announce Positive Phase 3 Results for RZL-012 in Submental Fat Reduction, Clearing the Path to a China NDA Filing

  September 2, 2026

   · 

  3 min read
• Press Releases

  Sitryx to Participate in Upcoming Investor Conferences - September 2, 2026

  September 2, 2026

   · 

  1 min read
• Press Releases

  United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis

  September 2, 2026

   · 

  10 min read
• Press Releases

  Elucid Raises $55 Million in Oversubscribed Series D Financing

  September 2, 2026

   · 

  3 min read
• Press Releases

  Novocure Announces Upcoming September 2026 Investor Events

  September 2, 2026

   · 

  3 min read